FUMAGALLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 7.745
AS - Asia 4.703
EU - Europa 3.266
SA - Sud America 634
AF - Africa 111
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 6
Totale 16.493
Nazione #
US - Stati Uniti d'America 7.584
SG - Singapore 1.678
CN - Cina 1.016
VN - Vietnam 672
HK - Hong Kong 610
IT - Italia 567
RU - Federazione Russa 558
DE - Germania 509
BR - Brasile 471
SE - Svezia 451
GB - Regno Unito 278
IE - Irlanda 270
FR - Francia 165
IN - India 158
CA - Canada 102
KR - Corea 89
UA - Ucraina 82
ID - Indonesia 75
BD - Bangladesh 72
FI - Finlandia 68
TR - Turchia 68
DK - Danimarca 67
AR - Argentina 64
JP - Giappone 49
NL - Olanda 40
AT - Austria 38
ZA - Sudafrica 38
LT - Lituania 35
MX - Messico 34
IQ - Iraq 33
ES - Italia 27
PL - Polonia 27
BE - Belgio 24
CO - Colombia 24
SA - Arabia Saudita 24
AU - Australia 23
PK - Pakistan 23
EC - Ecuador 22
EG - Egitto 19
PH - Filippine 19
CH - Svizzera 15
VE - Venezuela 15
PY - Paraguay 14
ET - Etiopia 13
KZ - Kazakistan 12
IR - Iran 11
UZ - Uzbekistan 11
MY - Malesia 10
TN - Tunisia 10
JO - Giordania 9
TW - Taiwan 9
RO - Romania 8
UY - Uruguay 8
CL - Cile 7
HR - Croazia 7
MA - Marocco 7
NP - Nepal 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
IL - Israele 6
TH - Thailandia 6
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
EU - Europa 5
OM - Oman 5
PA - Panama 5
PT - Portogallo 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
DZ - Algeria 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KE - Kenya 3
LY - Libia 3
PE - Perù 3
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LB - Libano 2
MM - Myanmar 2
MU - Mauritius 2
NO - Norvegia 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 16.480
Città #
Ann Arbor 1.897
Singapore 1.032
Dallas 603
Hong Kong 588
Ashburn 566
San Jose 458
Wilmington 347
Chandler 323
Frankfurt am Main 289
Dublin 262
Milan 237
Dearborn 236
Woodbridge 185
New York 183
Los Angeles 181
Ho Chi Minh City 173
Houston 157
Santa Clara 149
Hanoi 144
Fairfield 139
Beijing 136
Princeton 134
Nanjing 113
Chicago 112
Jacksonville 88
Boardman 81
The Dalles 77
Seattle 69
Guangzhou 67
Moscow 65
Lauterbourg 63
Seoul 62
Council Bluffs 60
Jakarta 53
Shanghai 49
Basingstoke 46
Buffalo 44
Nanchang 42
Orem 42
Dong Ket 41
São Paulo 40
Cambridge 38
Helsinki 37
Lawrence 32
Munich 31
Vienna 31
Shenyang 29
Vilnius 28
Da Nang 27
Altamura 26
Hangzhou 25
Toronto 25
Chennai 24
Hefei 24
Zhengzhou 24
Atlanta 23
Denver 22
Montreal 22
Phoenix 22
Pune 22
Shangdi 21
Tokyo 21
Haiphong 20
Jinan 20
Brussels 19
London 19
Ottawa 19
Warsaw 19
Rio de Janeiro 18
Brooklyn 17
Kunming 17
Manchester 17
Sacramento 17
Baghdad 16
Changsha 16
Sydney 16
Tianjin 16
Andover 15
Fremont 15
Falls Church 14
Johannesburg 14
Kent 14
Kocaeli 14
Mainz 14
Poplar 14
Portland 14
Addis Ababa 13
Belo Horizonte 13
Redondo Beach 13
Rome 13
Stockholm 13
Dhaka 12
Edmonton 12
Ha Long 12
Hải Dương 12
Mexico City 12
Nuremberg 12
San Diego 12
San Francisco 12
Cairo 11
Totale 10.753
Nome #
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 447
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 445
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 423
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 416
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 404
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 390
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 378
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 369
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 367
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 365
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 340
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 328
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 315
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 308
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 305
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 297
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 295
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 292
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 289
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 285
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 281
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 280
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 269
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 269
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 268
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 264
Multimodal experimental approach to the study of human neurological diseases 260
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 259
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 254
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 244
Genetic factors influencing the development of vincristine-induced neurotoxicity 244
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 232
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 226
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 224
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 222
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 218
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 216
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 216
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 212
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 210
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 208
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 207
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 204
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 202
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 202
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 201
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 198
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 198
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 198
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 197
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 192
In vitro neurotoxicity of new promising metal-based anticancer complexes 192
Pharmacokinetics of IVIg in Wistar rats 191
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 189
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 188
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 188
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 188
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 181
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 180
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 175
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 165
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 164
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 164
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 159
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 158
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 153
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 149
Blood NfL as a potential axonal damage marker in different CIPN rat models. 126
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 121
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 118
Totale 17.282
Categoria #
all - tutte 52.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021404 0 0 0 0 0 0 0 0 0 0 163 241
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/20252.773 139 363 248 115 236 92 189 97 286 396 222 390
2025/20266.203 754 464 855 581 633 388 1.070 314 530 556 58 0
Totale 17.282